GSK256471
GSK256471 is a non-peptide tachykinin NK3 receptor antagonist with a pKi of 8.9 for the human recombinant NK3 receptor and 8.4 for the guinea pig native receptor. GSK256471 exhibits >100-fold selectivity for NK1 (pKi = 5.2) and NK2 (pKi = 7.3) receptors. GSK256471 noncompetitively inhibits neurokinin B (NKB) (HY-P0242)-induced inositol phosphate accumulation, and this inhibition is irreversible. GSK256471 inhibits wet dog shaking behavior and suppresses dopamine release. GSK256471 could be used to study schizophrenia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1133706-08-7
- 分子式: C29H29N3O3S
- 分子量:499.62
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
IC50 & Target
[2]|
NK3R 8.9 (pIC50) |
体外実験
GSK256471 inhibits the intracellular calcium release induced by NKB with a pKi of 8.9[1].
GSK256471 (0.01-1 μM) causes the NKB concentration-response curve to shift to the right and significantly reduces the maximum response (Emax), indicating the non-competitive antagonistic property in U2OS cells[2].
GSK256471 (0.1-1 μM) completely abolished the neuronal discharge caused by NKB in U2OS cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
体内実験
GSK256471 (1 ng/kg-100 mg/kg, i.p., single dose) achieves effective receptor occupation at low brain concentrations with an EC50 of 8 ng/g[2].
GSK256471 (3-30 mg/kg, i.p., single dose) effectively blocks the function of the central NK3 receptor and inhibits the "wet dog shake" behavior in guinea pigs[2].
GSK256471 (1-30 mg/kg, i.p., single dose) regulates the excessive activity of the mesolimbic dopamine system in the brain of guinea pigs, suggesting its potential as an antipsychotic agent[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:"Wet dog shake" behavior model established in guinea pig[2]
-
Dosage:3, 10 and 30 mg/kg
-
Administration:Intraperitoneal injection (i.p.), single dose
-
Result:Significantly inhibited behavior at 10 and 30 mg/kg.
-
Animal Model:Model of dopamine release in the nucleus accumbens established in guinea pig[2]
-
Dosage:0.5, 1, 3, 10 and 30 mg/kg
-
Administration:Intraperitoneal injection (i.p.), single dose
-
Result:Significantly inhibited dopamine release at 1-10 mg/kg, but the effect disappeared at 30 mg/kg, presenting a "bell-shaped curve".
化学情報
-
CAS 番号 1133706-08-7
-
分子量 499.62
-
分子式 C29H29N3O3S
-
SMILES
O=C(N[C@H](C1=CC=CC=C1)C2CC2)C3=C(C(C4=CC=CC=C4)=NC5=CC=CC=C35)CN(S(=O)(C)=O)C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Smith PW, et al. New quinoline NK3 receptor antagonists with CNS activity. Bioorg Med Chem Lett. 2009 Feb 1;19(3):837-40. [Content Brief]
[2]. Dawson LA, et al. In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics. Eur J Pharmacol. 2010 Feb 10;627(1-3):106-14. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
GSK256471 関連分類
HY-116268 関連分類
Powered by Bioz